Tolerance of efavirenz in children

AIDS. 2001 Jan 26;15(2):241-3. doi: 10.1097/00002030-200101260-00014.

Abstract

Objective: To extend the limited knowledge of efavirenz tolerance in children.

Method: An observational study of 33 children given efavirenz combined with various others agents and followed in a single institution.

Results: Fifteen (42%) of the children presented at least one clinically discernable side effect, cutaneous (n = 5), nervous system (n = 10), or both (n = 2). Intolerance led to treatment interruption in seven children but the main symptom was transitory dizziness or other signs similar to those observed in adults.

Conclusion: Early, often transient nervous system side effects require careful preparation with the child and his family to avoid premature and inadequate withdrawal from treatment.

MeSH terms

  • Adolescent
  • Alkynes
  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use
  • Benzoxazines
  • CD4 Lymphocyte Count
  • Child
  • Cyclopropanes
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology
  • Humans
  • Oxazines / adverse effects*
  • Oxazines / therapeutic use
  • Reverse Transcriptase Inhibitors / adverse effects*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Viral Load

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • efavirenz